Stock listing
NASDAQ:FLGT Fulgent Genetics, Inc. Stock
Home listing (NASDAQ) of Fulgent Genetics, Inc.
Follow Fulgent Genetics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:FLGT
$24.12 USD -1.01 (-4.0%)
Close on Nov 20, 2026
- Day range
- $23.88 – $24.79 USDNov 20, 2026
- Volume
- 322,967 sharesNov 20, 2026
- Market cap
- $673.9M USDAt the close on Nov 20, 2026 · price × 27.94M shares outstanding
- 52-week range
- $13.46 – $31.04 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $7.12M USDMedian day 297,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FLGT · Home | $24.12 USD | -1.01 (-4.0%) | 322,967 | $24.12 | $24.79 | $23.88 | $25.13 | Close on Nov 20, 2026 |
| Frankfurt:7F0 | €22.40 EUR | -0.60 (-2.6%) | — | €22.40 | €22.40 | €22.40 | €23.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FLGT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $24.12 | -1.01 | -4.0% | $24.12 | $24.79 | $23.88 | 322,967 | |
| $25.13 | +0.92 | +3.8% | $24.08 | $25.49 | $23.84 | 392,965 | |
| $24.21 | +0.135 | +0.6% | $24.12 | $24.23 | $23.39 | 274,556 | |
| $24.08 | -0.585 | -2.4% | $24.47 | $24.47 | $23.88 | 267,143 | |
| $24.66 | -0.19 | -0.8% | $24.85 | $25.01 | $24.35 | 262,096 | |
| $24.85 | -0.85 | -3.3% | $25.41 | $25.73 | $24.55 | 287,387 | |
| $25.70 | -0.08 | -0.3% | $26.00 | $26.73 | $25.29 | 494,573 | |
| $25.78 | -0.37 | -1.4% | $26.50 | $27.41 | $25.53 | 616,856 | |
| $26.15 | +2.41 | +10.2% | $23.86 | $26.66 | $23.32 | 973,963 | |
| $23.74 | +5.08 | +27.2% | $20.47 | $23.85 | $19.64 | 1,097,400 | |
| $18.66 | -1.02 | -5.2% | $19.59 | $19.63 | $18.44 | 388,300 | |
| $19.68 | +0.31 | +1.6% | $19.74 | $19.99 | $19.30 | 364,000 | |
| $19.37 | +0.08 | +0.4% | $19.41 | $19.73 | $19.19 | 284,400 | |
| $19.29 | -1.33 | -6.5% | $20.82 | $20.84 | $19.05 | 339,400 | |
| $20.62 | -1.06 | -4.9% | $21.50 | $21.77 | $20.54 | 201,400 | |
| $21.68 | +0.16 | +0.7% | $21.64 | $21.72 | $21.14 | 210,100 | |
| $21.52 | +0.82 | +4.0% | $20.64 | $21.52 | $20.64 | 397,600 | |
| $20.70 | +0.48 | +2.4% | $20.19 | $20.73 | $20.08 | 355,600 | |
| $20.22 | +0.12 | +0.6% | $20.14 | $20.53 | $20.14 | 191,200 | |
| $20.10 | +0.11 | +0.6% | $19.85 | $20.28 | $19.65 | 240,100 | |
| $19.99 | -0.14 | -0.7% | $20.08 | $20.24 | $19.30 | 278,900 | |
| $20.13 | -0.20 | -1.0% | $20.21 | $20.50 | $19.98 | 193,800 | |
| $20.33 | +0.23 | +1.1% | $20.19 | $20.67 | $19.96 | 161,000 | |
| $20.10 | +0.29 | +1.5% | $19.89 | $20.39 | $19.89 | 212,700 | |
| $19.81 | -1.53 | -7.2% | $21.45 | $21.49 | $19.73 | 443,400 | |
| $21.34 | +0.33 | +1.6% | $21.05 | $21.50 | $20.86 | 139,700 | |
| $21.01 | -0.05 | -0.2% | $20.84 | $21.44 | $20.65 | 352,100 | |
| $21.06 | -0.41 | -1.9% | $21.47 | $21.60 | $21.06 | 201,300 | |
| $21.47 | -0.27 | -1.2% | $21.74 | $21.80 | $21.22 | 228,000 | |
| $21.74 | +0.92 | +4.4% | $20.82 | $21.79 | $20.82 | 253,900 | |
| $20.82 | +0.25 | +1.2% | $20.49 | $20.88 | $19.82 | 427,900 | |
| $20.57 | -0.01 | 0.0% | $20.48 | $20.70 | $19.90 | 298,300 | |
| $20.58 | -1.87 | -8.3% | $22.43 | $22.78 | $20.46 | 368,600 | |
| $22.45 | +0.97 | +4.5% | $21.37 | $22.47 | $21.28 | 308,000 | |
| $21.48 | +0.18 | +0.8% | $21.64 | $21.64 | $21.07 | 297,600 | |
| $21.30 | -0.72 | -3.3% | $21.99 | $22.05 | $21.12 | 338,200 | |
| $22.02 | -0.06 | -0.3% | $22.07 | $22.25 | $21.69 | 273,500 | |
| $22.08 | -0.28 | -1.3% | $22.29 | $22.59 | $21.88 | 234,800 | |
| $22.36 | +0.16 | +0.7% | $21.99 | $22.39 | $21.83 | 248,600 | |
| $22.20 | +0.65 | +3.0% | $21.69 | $22.25 | $21.36 | 247,000 | |
| $21.55 | +0.28 | +1.3% | $21.28 | $21.87 | $21.28 | 369,600 | |
| $21.27 | -0.38 | -1.8% | $21.52 | $21.63 | $21.12 | 190,300 | |
| $21.65 | +0.11 | +0.5% | $21.52 | $21.84 | $21.35 | 252,300 | |
| $21.54 | -0.15 | -0.7% | $21.93 | $21.93 | $21.01 | 348,800 | |
| $21.69 | -0.16 | -0.7% | $21.70 | $21.88 | $21.41 | 669,200 | |
| $21.85 | +0.22 | +1.0% | $21.59 | $21.88 | $21.37 | 312,000 | |
| $21.63 | +0.35 | +1.6% | $21.31 | $21.81 | $21.20 | 328,300 | |
| $21.28 | +0.63 | +3.1% | $20.60 | $21.31 | $20.60 | 479,900 | |
| $20.65 | +0.20 | +1.0% | $20.46 | $20.80 | $20.10 | 336,300 | |
| $20.45 | +0.33 | +1.6% | $20.30 | $20.52 | $19.86 | 380,500 | |
| $20.12 | +0.27 | +1.4% | $19.69 | $20.16 | $19.46 | 337,300 | |
| $19.85 | -0.35 | -1.7% | $20.09 | $20.10 | $19.61 | 369,900 | |
| $20.20 | +0.47 | +2.4% | $19.55 | $20.23 | $19.44 | 375,000 | |
| $19.73 | +0.08 | +0.4% | $19.54 | $19.86 | $19.38 | 225,000 | |
| $19.65 | -0.39 | -1.9% | $20.11 | $20.34 | $19.46 | 283,500 | |
| $20.04 | +0.45 | +2.3% | $19.59 | $20.20 | $19.59 | 412,400 | |
| $19.59 | +0.22 | +1.1% | $19.29 | $19.85 | $19.29 | 285,600 | |
| $19.37 | -0.24 | -1.2% | $19.42 | $19.54 | $19.04 | 407,400 | |
| $19.61 | -0.34 | -1.7% | $19.88 | $19.93 | $19.49 | 192,500 | |
| $19.95 | +0.14 | +0.7% | $19.74 | $20.21 | $19.74 | 212,500 | |
| $19.81 | -0.14 | -0.7% | $19.96 | $20.00 | $19.75 | 170,800 | |
| $19.95 | +0.50 | +2.6% | $19.50 | $20.06 | $19.35 | 185,400 | |
| $19.45 | -0.45 | -2.3% | $19.89 | $19.91 | $19.19 | 259,900 | |
| $19.90 | -0.02 | -0.1% | $20.01 | $20.04 | $19.57 | 324,000 | |
| $19.92 | +0.18 | +0.9% | $19.60 | $20.52 | $19.58 | 203,700 |
- Ticker
- NASDAQ:FLGT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 5, 2026
Fulgent Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 5, 2026
Fulgent Genetics (NASDAQ:FLGT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 44 slides
Latest news
Fulgent Reports Third Quarter 2026 Financial Results
Nov 5, 2026
Closed $23.74 (+27.2%) on Nov 6, 2026
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Oct 15, 2026
Closed $19.81 (-7.2%) on Oct 16, 2026
Fulgent Reports Second Quarter 2026 Financial Results
Jul 30, 2026
Closed $20.21 (+2.9%) on Jul 30, 2026
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
Jul 9, 2026
Closed $20.55 (-1.6%) on Jul 10, 2026
Flagship Pioneering Announces Formation of Terion, a Company Delivering the Digital Infrastructure to Power Modern Agriculture
Jun 18, 2026
Closed $18.00 (+1.7%) on Jun 18, 2026
Fulgent Presents Updated FID-007 Data at ASCO 2026
Jun 1, 2026
Closed $18.70 (+3.4%) on Jun 2, 2026
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
May 21, 2026
Closed $17.11 (-1.6%) on May 22, 2026
Fulgent Reports First Quarter 2026 Financial Results
May 1, 2026
Closed $14.13 (-7.0%) on May 1, 2026
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
Apr 22, 2026
Closed $16.03 (-1.6%) on Apr 23, 2026
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
Apr 16, 2026
Closed $16.13 (-0.2%) on Apr 16, 2026
Fulgent Genetics, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 14 in the last 12 months · 128 in all · newest Nov 5, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 24 decks · latest Nov 5, 2026
Where Fulgent Genetics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FLGT · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2AS4N | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2AS4N | Lang & Schwarz | Germany | EUR |
| BMV:FLGT | BMV | Mexico | MXN |
| BIVA:FLGT | BIVA | Mexico | MXN |
| gettex:7F0 | gettex | Germany | EUR |
| BOATS:FLGT | BOATS | United States | USD |
| Frankfurt:7F0 | Frankfurt | Germany | EUR |
| Dusseldorf:7F0 | Dusseldorf | Germany | EUR |
| Munich:7F0 | Munich | Germany | EUR |
| Stuttgart:7F0 | Stuttgart | Germany | EUR |
| Tradegate:7F0 | Tradegate | Germany | EUR |
Valuation
EV/sales 1.2× against a median of 1.5×: 2nd lowest of 11 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $381.6M USD
- P/E
- Loss
- EV/sales
- 1.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.7×
- Gross margin
- 33.8%
- Operating margin
- −39.2%
- Net margin
- −27.5%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.99
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics, Inc. · NASDAQ:FLGT | US$673.9M | US$381.6M | n/a | 1.2× | n/a | 0.7× | −27.5% | 0.0× | 0.99 |
| Gushengtang Holdings Limited · HKEX:2273 | US$716.5M | US$752.4M | 13.5× | 1.5× | 7.9× | 2.5× | 10.9% | 0.8× | n/a |
| Nephrocare Health Services Limited · NSE:NEPHROPLUS | US$711.7M | US$656.6M | 51.5× | 5.5× | 24.8× | 5.5× | 11.5% | 0.0× | n/a |
| Phreesia, Inc. · NYSE:PHR | US$708.2M | US$634.7M | 67.8× | 1.3× | 12.8× | 1.9× | 2.1% | 0.0× | 0.42 |
| Jinxin Fertility Group Ltd. · HKEX:1951 | US$692.5M | US$1.02B | n/a | 2.6× | 12.6× | 0.5× | −36.9% | 0.3× | n/a |
| Xunfei Healthcare Technology Co., Ltd. · HKEX:2506 | US$682.0M | US$664.6M | n/a | 4.8× | n/a | 5.3× | −7.1% | 0.1× | n/a |
| Bright Eye Hospital Group Co., Ltd. Class A · SZSE:301239 | US$671.3M | US$637.2M | 60.6× | 1.4× | n/a | 2.1× | 2.4% | 0.1× | n/a |
| Shanghai Runda Medical Technology Co., Ltd. Class A · SSE:603108 | US$663.4M | US$591.1M | n/a | 0.6× | n/a | 1.2× | −8.6% | 0.1× | n/a |
| PT Metro Healthcare Indonesia Tbk · IDX:CARE | US$651.9M | US$684.4M | 1,733× | 21.8× | n/a | 3.9× | 1.2% | 0.5× | n/a |
| Wuxi Commercial Mansion Grand Orient Co., Ltd. Class A · SSE:600327 | US$641.4M | US$572.2M | n/a | 1.5× | n/a | 1.6× | −11.5% | 0.0× | n/a |
| Ramkhamhaeng Hospital Public Co. Ltd. · SET:RAM | US$625.3M | US$904.8M | 7.7× | 1.5× | 8.4× | 0.9× | 13.5% | 0.5× | n/a |
| Median of the others | US$676.6M | US$660.6M | 56.0× | 1.5× | 12.6× | 2.0× | 1.6% | 0.1× | 0.42 |
Forecasts
1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 25.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -1.70 · 1 analyst
- Revenue, year to Dec 2026
- 335.1M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Ming Hsieh | Chairman of our Board of Directors and Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Ming Hsieh | Chairman of our Board of Directors and Chief Executive Officer |
| Linda Marsh | Director |
| Michael Nohaile | Director |
| Reggie Groves | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Fulgent Genetics (NASDAQ:FLGT) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 4:30 PM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q2 2026 Earnings Call | Thu, Jul 30, 2026 · 4:30 PM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q1 2026 Earnings Call | Fri, May 01, 2026 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q4 2025 Earnings Call | Fri, Feb 27, 2026 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q3 2025 Earnings Call | Fri, Nov 07, 2025 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q2 2025 Earnings Call | Fri, Aug 01, 2025 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q1 2025 Earnings Call | Fri, May 02, 2025 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q4 2024 Earnings Call | Fri, Feb 28, 2025 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q3 2024 Earnings Call | Fri, Nov 08, 2024 · 8:30 AM ET | Replay |
| Fulgent Genetics (NASDAQ:FLGT) Q2 2024 Earnings Call | Fri, Aug 02, 2024 · 8:30 AM ET | Replay |
All 27 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +27.2% |
| Q2 2026 | Jul 30, 2026 · After close | −18.1% |
| Q1 2026 | May 1, 2026 · Before open | −7.0% |
| Q4 2025 | Feb 26, 2026 | −34.9% |
| Q3 2025 | Nov 7, 2025 · Before open | +18.1% |
| Q2 2025 | Aug 1, 2025 · Before open | +7.9% |
| Q1 2025 | May 2, 2025 · Before open | +19.1% |
| Q4 2024 | Feb 26, 2025 · Before open | −0.3% |
| Q3 2024 | Nov 8, 2024 · Before open | −11.8% |
| Q2 2024 | Aug 2, 2024 · Before open | +6.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 3, 2024 · Before open | +1.2% |
| Q4 2023 | Feb 28, 2024 · Before open | −8.1% |
| Q3 2023 | Nov 3, 2023 · Before open | +13.2% |
| Q2 2023 | Aug 4, 2023 · Before open | −3.0% |
| Q1 2023 | May 5, 2023 · Before open | +19.0% |
| Q4 2022 | Feb 28, 2023 · After close | −2.9% |
| Q3 2022 | Nov 7, 2022 · After close | −2.3% |
| Q2 2022 | Aug 4, 2022 · After close | −6.1% |
| Q1 2022 | May 3, 2022 · After close | +3.6% |
| Q4 2021 | Feb 23, 2022 · After close | +2.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 44 slides | Nov 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 49 slides | Jul 30, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 52 slides | May 1, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 51 slides | Feb 27, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 51 slides | Nov 7, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 36 slides | Aug 1, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 36 slides | May 2, 2025 |
| Investor Presentation (February 2025) | Investor deck | 39 slides | Feb 28, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 39 slides | Nov 8, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 37 slides | Aug 2, 2024 |
All 24 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2024 Earnings Presentation | Earnings | 37 slides | May 3, 2024 |
| Investor Presentation (February 2024) | Investor deck | 37 slides | Feb 28, 2024 |
| Investor Presentation (November 2023) | Investor deck | 37 slides | Nov 3, 2023 |
| Investor Presentation (August 2023) | Investor deck | 37 slides | Aug 4, 2023 |
| Investor Presentation (May 2023) | Investor deck | 36 slides | May 5, 2023 |
| Raymond James & Associates' 44th Annual Institutional Investors Conference (March 2023) | Conference | 25 slides | Mar 7, 2023 |
| Investor Presentation (February 2023) | Investor deck | 36 slides | Feb 28, 2023 |
| Investor Presentation (November 2022) | Investor deck | 28 slides | Nov 7, 2022 |
| Q3 2022 Earnings Presentation | Earnings | 20 slides | Nov 7, 2022 |
| Q2 2022 Earnings Presentation | Earnings | 28 slides | Aug 4, 2022 |
| Q1 2022 Earnings Presentation | Earnings | 28 slides | May 3, 2022 |
| Q4 2021 Earnings Presentation | Earnings | 29 slides | Feb 23, 2022 |
| Q3 2021 Earnings Presentation | Earnings | 28 slides | Nov 9, 2021 |
| Q2 2021 Earnings Presentation | Earnings | 28 slides | Aug 9, 2021 |
IPO
Priced at US$9.00 a share on Sep 28, 2016.
- Price
- US$9.00 a share
- Shares offered
- 4,200,000 shares of common stock
- Offering size
- US$37.8 million
- Underwriters' option
- Up to 630,000 more shares
- Underwriters
- Credit Suisse, Piper Jaffray, Raymond James, BTIG · In the order on the cover
- Shares delivered
- On or about Oct 4, 2016
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 9, 2016 |
| Filed publicly | Sep 2, 2016 |
| Amended 3 times | Newest Sep 28, 2016 |
| Shares registered with an exchange | Sep 26, 2016 |
| Declared effective by the SEC | Sep 28, 2016 |
| Final prospectus, with the price | Sep 29, 2016 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 29, 2016 |
| EFFECT · Notice that a registration is effective | Sep 28, 2016 |
| CORRESP · Letter to the SEC | Sep 28, 2016 |
| CORRESP · Letter to the SEC | Sep 28, 2016 |
| FWP · Free writing prospectus | Sep 28, 2016 |
| S-1/A · Registration statement, amended | Sep 28, 2016 |
| CERTNAS · Nasdaq's certificate of listing | Sep 27, 2016 |
| FWP · Free writing prospectus | Sep 26, 2016 |
| CORRESP · Letter to the SEC | Sep 26, 2016 |
| S-1/A · Registration statement, amended | Sep 26, 2016 |
All 23 filings
| Filing | Filed |
|---|---|
| 8-A12B · Registration of shares for listing on an exchange | Sep 26, 2016 |
| UPLOAD · Letter from the SEC | Sep 23, 2016 |
| CORRESP · Letter to the SEC | Sep 23, 2016 |
| CORRESP · Letter to the SEC | Sep 23, 2016 |
| S-1/A · Registration statement, amended | Sep 19, 2016 |
| CORRESP · Letter to the SEC | Sep 8, 2016 |
| S-1 · Registration statement | Sep 2, 2016 |
| UPLOAD · Letter from the SEC | Aug 29, 2016 |
| DRS/A · Draft registration statement, amended | Aug 18, 2016 |
| UPLOAD · Letter from the SEC | Aug 1, 2016 |
| DRS/A · Draft registration statement, amended | Jul 15, 2016 |
| UPLOAD · Letter from the SEC | Jul 7, 2016 |
| DRS · Draft registration statement | Jun 9, 2016 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 29, 2016
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 322.7M | 283.5M | 289.2M | 619.0M | 992.6M | 421.7M | 32.5M | 21.4M | 18.7M | 18.3M |
| Cost of revenue | 191.8M | 176.3M | 184.8M | 252.1M | 215.5M | 89.8M | 14.1M | 10.7M | 8.55M | 6.72M |
| Gross profit | 130.9M | 107.2M | 104.5M | 366.9M | 777.1M | 331.9M | 18.4M | 10.7M | 10.2M | 11.6M |
| Research and development | 53.9M | 48.8M | 41.4M | 28.9M | 24.2M | 11.6M | 6.54M | 5.53M | 4.22M | 3.56M |
| Selling, general and administrative | 116.7M | 88.1M | 89.0M | 111.1M | 50.7M | 15.2M | 6.41M | 5.54M | 5.13M | 4.61M |
| Operating income | -91.1M | -73.9M | -195.5M | 178.5M | 676.0M | 290.2M | -428.0K | -5.07M | -3.48M | 918.0K |
| Depreciation and amortization | 24.1M | 24.9M | 26.1M | 32.7M | 11.0M | 2.96M | 2.11M | 2.16M | 1.73M | 1.17M |
| EBITDA | -67.0M | -49.0M | -169.4M | 211.2M | 687.0M | 293.1M | 1.68M | -2.91M | -1.75M | 2.09M |
| Interest expense | 75.0K | -170.0K | 488.0K | 346.0K | 117.0K | 20.0K | 2.17M | 0 | 0 | 5.39M |
| Income before tax | -70.0M | -52.0M | -174.1M | 184.0M | 677.3M | 291.7M | 409.0K | -4.64M | -3.00M | -4.47M |
| Income tax | -8.39M | -8.14M | 1.15M | 42.1M | 174.8M | 72.5M | 43.0K | 36.0K | -1.01M | 920.0K |
| Net income | -60.5M | -42.7M | -167.8M | 143.4M | 507.4M | 214.3M | -411.0K | -5.61M | -2.51M | -5.35M |
| Earnings per share, basic | -1.95 | -1.38 | -5.66 | 4.87 | 16.82 | 7.61 | -0.02 | -0.31 | -0.14 | -0.30 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 50.2M | 55.1M | 97.5M | 79.5M | 164.9M | 87.4M | 12.0M | 6.74M | 6.49M | 7.90M |
| Short-term investments | 285.9M | 203.0M | 326.7M | 446.7M | 285.6M | 211.9M | 16.3M | 24.3M | 20.0M | 38.6M |
| Receivables | 84.8M | 69.0M | 51.1M | 52.7M | 138.9M | 183.9M | 6.55M | 5.95M | 4.00M | 4.36M |
| Inventory | 10.6M | 8.38M | 5.83M | 4.28M | 12.2M | 16.5M | 277.0K | 314.0K | 231.0K | 322.0K |
| Current assets | 550.5M | 353.6M | 507.8M | 627.9M | 612.0M | 523.6M | 37.1M | 39.5M | 32.9M | 26.1M |
| Property, plant and equipment | 112.5M | 105.5M | 83.5M | 81.4M | 62.3M | 40.2M | 5.97M | 6.45M | 7.27M | 6.23M |
| Goodwill | 25.1M | 22.1M | 22.1M | 143.0M | 50.9M | 0 | 0 | 0 | ||
| Total assets | 1.21B | 1.22B | 1.24B | 1.39B | 1.28B | 700.5M | 88.8M | 53.9M | 57.2M | 58.0M |
| Accounts payable | 18.7M | 18.4M | 15.4M | 23.1M | 20.5M | 26.5M | 1.58M | 1.31M | 2.09M | 2.76M |
| Current liabilities | 85.0M | 72.9M | 73.0M | 88.1M | 105.3M | 130.1M | 3.72M | 2.74M | 3.00M | 3.32M |
| Long-term debt | 1.96M | 2.49M | 2.96M | 3.37M | 0 | 0 | ||||
| Total debt | 7.68M | 8.47M | 15.3M | 38.9M | 21.3M | 15.9M | 2.68M | |||
| Total liabilities | 106.8M | 90.8M | 102.0M | 116.2M | 112.8M | 131.1M | 5.98M | 2.75M | 3.01M | 3.56M |
| Shareholders' equity | 1.11B | 1.13B | 1.14B | 1.27B | 1.16B | 569.4M | 82.8M | 51.2M | 54.2M | 54.5M |
| Shares outstanding | 31.1M | 30.8M | 29.7M | 29.4M | 30.2M | 28.2M | 21.5M | 18.2M | 17.8M | 17.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -101.6M | 21.1M | 27.0M | 253.5M | 538.6M | 140.6M | 5.52M | -675.0K | 1.33M | 4.41M |
| Capital spending | -22.6M | -40.3M | -22.2M | -18.8M | -23.8M | -35.1M | -1.18M | -2.32M | -2.90M | -3.79M |
| Free cash flow | -124.2M | -19.3M | 4.80M | 234.7M | 514.8M | 105.5M | 4.33M | -3.00M | -1.56M | 617.0K |
| Cash from investing | 111.4M | -58.4M | 38.9M | -261.3M | -546.5M | -326.4M | -29.0M | 950.0K | -2.05M | -42.8M |
| Cash from financing | -14.8M | -4.85M | -47.8M | -77.1M | 85.4M | 261.3M | 28.8M | 15.0K | -770.0K | 45.8M |
| Dividends paid | -4.16M | -15.0M | 0 | -4.59M | ||||||
| Share buybacks | -10.9M | -225.0K | -25.1M | -74.3M | -4.16M | -62.0K | -21.0K | 15.0K | 31.0K | -6.59M |
| Change in cash | -4.95M | -42.2M | 18.0M | -85.4M | 77.5M | 75.5M | 5.23M | 246.0K | -1.41M | 7.40M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 18, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 27, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 27, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| 4 · Change in ownership | Jul 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 8-K · Current report | May 21, 2026 | Current report | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 14, 2026 | Offer document | SEC |
| 8-K · Current report | May 14, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | May 1, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 1, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Mar 31, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 31, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Mar 31, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 31, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 31, 2026 | Meeting notice | SEC |
| 8-K · Current report | Mar 17, 2026 | Acquisition or disposal | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 4, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 22, 2025 | Material contract | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 26, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 26, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 24, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 19, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2025 | Results | SEC |
| 4 · Change in ownership | Oct 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 28, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 20, 2025 | Current report | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 28, 2025 | Insider trade | SEC |
| 144/A · Notice of proposed sale, amended | Aug 27, 2025 | Other filings | SEC |
| 144/A · Notice of proposed sale, amended | Aug 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 27, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 27, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 5, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 1, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 8-K · Current report | May 15, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 13, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 6, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 2, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 3, 2025 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Mar 26, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 26, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 25, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 21, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 28, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 7, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 28, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 8, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 2, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 2, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 25, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 25, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 8, 2024 | Results | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 5, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2024 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 3, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 27, 2024 | Other filings | SEC |
| 4 · Change in ownership | Aug 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 5, 2024 | Insider trade | SEC |
This page holds 200 of 671 filings. Open Filings
Cap table
Built by 6ix from Fulgent Genetics, Inc.’s releases · as of Nov 2, 2026
- Common shares
- 27,939,000
- Fully diluted
- 27,939,000
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 27,939,000 | Nov 2, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 2, 2026 | 27,939,000 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John C Bolger Other companies: Tintri Inc (Director · Jun 29, 2017 – Jun 29, 2017 · Past); Mission West Properties Inc (Director · Jan 12, 2007 – Jan 2, 2008 · Past); Mattson Technology Inc (Director · Dec 12, 2006 – Jul 26, 2010 · Past); Integrated Device Technology Inc (Director · Nov 15, 2006 – Nov 15, 2007 · Past); Wind River Systems Inc (Director · Apr 1, 2006 – Jul 16, 2009 · Past) | Director · Sep 28, 2016 – Aug 1, 2022 · Past |
| Leonard Post Other companies: CG Oncology, Inc. (Chief Scientific Officer, Vivace Therapeutics · Since at least Jan 24, 2024); uniQure N.V. (Director · Since at least Jun 17, 2020); Praecis Pharmaceuticals Inc (Director · Feb 7, 2007 – Feb 7, 2007 · Past) | Director · Aug 1, 2022 – Aug 1, 2022 · Past |
| James Mulay Other companies: CG Oncology, Inc. (Director · Since at least Jan 24, 2024) | Director · Sep 28, 2016 – May 30, 2019 · Past |
| Linda Dong Other companies: Astrana Health Inc. (Director · Since at least Jan 11, 2019) | Director · Since at least Aug 1, 2019 |
| Ming Hsieh Other companies: Fortinet, Inc. (Director · Since at least Nov 6, 2017) | Chairman of our Board of Directors and Chief Executive Officer · Since at least Nov 9, 2017 |
| Paul Kim Other companies: Exagen Inc. (Board Member · Since at least Jul 24, 2023) | CFO and Treasurer · Since at least Aug 12, 2016 |
| Regina E. Groves Other companies: AtriCure, Inc. (Director · Since at least Mar 21, 2017) | Director · Since at least Jan 3, 2023 |
| Yun Yen Other companies: Lixte Biotechnology Holdings, Inc. (Director · Since at least Nov 30, 2020) | Director · Sep 28, 2016 – May 18, 2022 · Past |
| Hanlin Gao | Chief Scientific Officer · Since at least May 13, 2016 |
| Jian Xie | President and COO · Since at least Aug 3, 2020 |
All 13 people
| Person | Seat |
|---|---|
| Linda Marsh | Director · Since at least Nov 5, 2026 |
| Michael Nohaile | Director · Since at least Aug 1, 2022 |
| Reggie Groves | Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Fulgent Genetics, Inc.